A gesto adequada dessa condio de extrema importncia, uma vez que a falta de controle sobre os nveis de glicose sangunea pode resultar em complicaes graves, incluindo doenas cardiovasculares, danos renais, problemas oculares, neuropatia, problemas nos ps e at amputaes (BAGGIO
as the first therapy to help people manage their weight and reduce cardiovascular risks, Martin Holst Lange, executive vice president and head of development at Novo Nordisk, said in a separate statement
Type 1 diabetes patients do not have amylin treatment and, therefore, have unphysiological postprandial glucagon secretion, fast gastric emptying, and impaired satiety signaling, all of which are factors that can contribute to glycemic variability, postprandial hyperglycemia, and weight gain in intensive insulin therapy
Beyond its metabolic functions, GLP-1 is involved in regulating various behaviors, including feeding, fluid intake, and even motivated behaviors like drug consumption
By using GLP-1 injections in combination with a healthy diet and regular exercise, the Institute for Weight Management helps patients achieve sustainable weight loss results